Reported Jan 15, 2020 · Terminated

Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854,…

Appco Pharma LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Appco Pharma LLC · 262 Old New Brunswick Rd Unit N · Piscataway, NJ · 08854-3756

Is this the product you have?

    • Ranitidine Capsules 300 mg
    • 30 count bottles. Rx only
  • Manufactured byAppco Pharma LLC, Piscataway, NJ 08854
  • Distributed byANI Pharmaceuticals, Inc., Baudette, MN 56623, NDC 62559-691-30
Lot codes and dates
    • Batch # 1905227UE
    • exp. date Apr-2021 1905228UE
    • exp. date Apr-2021
Amount recalled
1,632 bottes

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Why it was recalled

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Appco Pharma LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Apr 24, 2020 · Data as of Sep 19, 5:03 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.